COMPOSITIONS FOR THE TREATMENT OF FABRICS COMPRISING CAPSULES OF BENEFICIATING AGENT

MX431592BActive Publication Date: 2026-02-25PROCTER & GAMBLE CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MX2021001772
Authority / Receiving Office
MX · MX
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-08-14
Filing Date
2021-02-12
Publication Date
2026-02-25
Estimated Expiration
2039-08-14

AI Technical Summary

Technical Problem

Existing fabric treatment compositions face challenges in effectively depositing benefit agent capsules, particularly perfume, due to their high cost and complexity when deposition aids are added, and the capsules are diluted in washing solutions, leading to reduced durability of benefits.

Method used

Incorporation of biphenyl brighteners and polyvinyl alcohol-derived shell materials in fabric treatment compositions to enhance the deposition of benefit agent capsules, utilizing the interaction between polyvinyl alcohol and biphenyl brighteners for improved capsule adherence.

Benefits of technology

The use of biphenyl brighteners and polyvinyl alcohol-based shell materials significantly enhances the deposition of benefit agent capsules on fabrics, resulting in more durable benefits with reduced manufacturing complexity and cost.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to fabric treatment compositions, as well as to the use thereof; such fabric treatment compositions comprise biphenyl brightening agent capsules; such fabric treatment compositions exhibit an improved deposition of the brightening agent capsule on fabrics, especially on cotton fabrics.
Need to check novelty before this filing date? Find Prior Art

Description

COMPOSITIONS FOR THE TREATMENT OF FABRICS COMPRISING CAPSULES OF BENEFICIATING AGENT FIELD OF INVENTION The invention relates to fabric treatment compositions comprising biphenyl brightening agent and beautifying agent capsules, and to the use thereof. BACKGROUND OF THE INVENTION Fabric treatment compositions used in the laundry process provide benefits to fabrics through the use of fabric brighteners. One example is the maintenance of a vibrant appearance provided by brighteners. Another example is the pleasant scent provided by perfumes. A problem in the field is that much of the fabric brightener, particularly perfume, is not deposited or rinsed away during fabric treatment. Since perfumes and other fabric brighteners are expensive components, encapsulation can be used to improve the release of the brightener during use. Typically, brightener capsules contain the brightener until the capsule ruptures during use, releasing the brightener.As such, after breaking the capsules of the beneficial agent containing perfume, the release of the perfume provides freshness benefits. It remains a challenge, however, to effectively deposit the benefit agent capsules onto treated fabrics, especially if the capsules are contained in a fabric treatment composition that is diluted in a washing solution during use to treat surfaces such as fabric fibers (e.g., laundry detergents or fabric softeners). Depositing aids have previously been identified to improve the deposition of the benefit agent capsules. However, adding depositing aids to fabric treatment compositions increases costs and complexity at the manufacturing site because an additional ingredient requires additional pumps and storage tanks. Therefore, there remains a need to improve the deposition of benefit agent capsules on fabrics to enhance the supply of benefit agents to provide more durable benefits during and after the use of the fabric treatment composition, while minimizing the cost and complexity of the fabric treatment composition formula. Patent No. WO2016049456 Al relates to capsule aggregates that 7! i Lnn / Lznz / E / Yi contain two or more beneficiation particles, each containing an active material and a polymeric material that immobilizes the active material; one or more binding polymers, each having an anionic chemical group with a negative charge or capable of acquiring a negative charge; and one or more depot polymers, each having a cationic chemical group with a positive charge or capable of acquiring a positive charge. Patent No. WO201701385 relates to beneficiation agent capsules coated with a particular mixture of copolymers. U.S. Patent No. 201701892831 relates to a microcapsule composition containing beneficiation agent capsules coated with a depot protein, e.g., a protein-silanol copolymer, a protein-silane copolymer, a protein-siloxane copolymer, or a cationicly modified protein. BRIEF DESCRIPTION OF THE INVENTION The invention relates to fabric treatment compositions comprising benefit agent capsules, wherein the benefit agent capsules comprise a coating material derived from polyvinyl alcohol and a coating component. The fabric treatment further comprises a surfactant and a biphenyl brightener. The invention also relates to wash water comprising the composition for the treatment of fabrics. The invention also relates to the use of such a composition for the treatment of fabrics to improve the deposition of the beneficial agent capsules. One objective of the invention is to improve the deposition of the beneficial agent capsules. DETAILED DESCRIPTION OF THE INVENTION Definitions As used in this description, the term fabric treatment composition is a subset of cleaning and treatment compositions that include, unless otherwise stated, high-performance or multi-purpose washing agents in granule or powder form, especially cleaning detergents; liquid, multi-purpose cleaning agents in gel or paste form, especially liquid types designated as high-performance; liquid detergents for fine fabrics; liquid cleaning and disinfecting agents; and fabric conditioning products including fabric softeners and / or softeners, which may be 7! i Lnn / Lznz / B / Yi in liquid, solid and / or dryer sheet form; as well as cleaning aids, such as bleaching additives and types of stain removers in stick or pretreatment form; products loaded onto substrates, such as dryer sheets, dry and wet pads and cloths, non-woven fabric substrates and sponges; as well as sprays and vaporizers. All such applicable products may be in a standard, concentrated or even highly concentrated form to the point of being, in certain respects, non-aqueous. As used herein, the articles a and a, when used in a claim, are to be construed as one or more of what is claimed or described. As used in this description, the terms include, encompass, and that include are understood to be non-limiting. As used in this description, the term solid includes product forms in granules, powder, bars, pellets, globules, and tablets. As used in this description, the term fluid includes the product forms of liquid, gel, paste, suspension, and gas. Unless otherwise stated, all component or composition levels refer to the active portion of that component or composition and exclude impurities, for example, residual solvents or by-products, which may be present in commercially available sources of such components or compositions. All percentages and ratios are calculated by weight unless otherwise stated. All percentages and ratios are calculated based on total composition unless otherwise stated. Each maximum numerical limit given in this specification shall be understood to include all lower numerical limits, as if the lower numerical limits were explicitly stated herein. All minimum numerical limits stated in this specification shall include all higher numerical limits, as if the higher numerical limits were expressly stated herein. Any numerical range given throughout this specification includes any lower numerical range that lies within that broader numerical range, as if the lower numerical range were expressly stated herein. Composition for the treatment of fabrics The fabric treatment composition according to the present invention comprises benefit agent capsules, wherein the benefit agent capsules comprise a shell material encapsulating a core material, wherein said shell material is derived from polyvinyl alcohol, and a cover component, wherein said cover component is selected from the list consisting of polyamine, melamine 7! i Lnn / Lznz / E / Yi formaldehyde, polyurea, polyurethane, polysaccharide, modified polysaccharide, formaldehyde-crosslinked urea, glutaraldehyde-crosslinked urea, silicon dioxide, sodium silicate, polyester, polyacrylamide, and mixtures thereof; said core material comprises a beneficiation agent. The fabric treatment composition further comprises a biphenyl brightener and preferably at least 1% surfactant. The fabric treatment composition may be a solid or a liquid; preferably the fabric treatment composition is a liquid. Biphenyl brightener. The fabric treatment composition of the present invention comprises a biphenyl brightener having the formula 7! i Lnn / Lznz / E / Yi where M is a suitable cation, preferably M is H+ or Na+, with greater preference M is Na+. It has been surprisingly discovered that the biphenyl brightener according to the present invention provides an improved deposit of the beneficiation agent capsules, wherein the beneficiation agent capsules comprise a shell material encapsulating a core material, and wherein said shell material is derived from polyvinyl alcohol and a coating component. Without any theoretical limitations, it is believed that the deposit is enhanced through the interaction between the polyvinyl alcohol and the biphenyl brightener according to the present invention. Examples of suitable biphenyl brighteners may be supplied under the trade name Tinopal® CBS-X, supplied by BASF; CF-351-UP Granular Brightener, supplied by Cenkey; CBX-X, supplied by Qingshan; Megawhite DT, supplied by Meghmani; Optical Brightener Agent 49 No. 3-E, supplied by Hongda; FL Brightener 49 CI 351, supplied by Alcochem; Keyfluor™ White ML, supplied by Milliken. In preferred fabric treatment compositions, less than 1%, more preferably less than 0.01%, of the total amount of biphenyl brightener, according to the present invention, in the fabric treatment composition is encapsulated in the benefiting agent capsules. The unencapsulated biphenyl brightener provides the treated fabrics with a vivid appearance and improved deposit of the benefiting agent capsule. In preferred compositions for the treatment of fabrics, the total level of biphenyl brightener is 0.01% to 2%, preferably 0.04% to 1.5%, with a higher preference of 0.06% to 1%, with the highest preference of 0.1% to 0.5%, by weight of the composition. In preferred compositions for the treatment of fabrics, the ratio of biphenyl brightener to benefit agent capsules is 50 / 1 to 1 / 500, with a higher preference of 10 / 1 to 1 / 250 and a maximum preference of 5 / 1 to 1 / 100. In one aspect of the invention, the level of biphenyl brightener in the wash water comprising the fabric treatment composition is from 0.1 to 50 ppm, preferably from 1 to 30 ppm, more preferably from 2 to 20 ppm, even more preferably from 2 to 10 ppm by weight of the wash water. The biphenyl brightener can be added separately to the fabric treatment composition comprising the other ingredients. Preferred fabric treatment compositions comprise the biphenyl brightener according to the present invention, wherein the biphenyl brightener is premixed before being added to the remaining ingredients of the fabric treatment composition, and wherein the premix comprises the biphenyl brightener, water, and a component selected from a list consisting of organic solvents, nonionic surfactant, and mixtures thereof; preferably wherein the organic solvent is selected from a list consisting of diethylene glycol, monoethanolamine, 1,2-propanediol, and mixtures thereof, most preferably wherein the organic solvent is 1,2-propanediol. The biphenyl brightener premix facilitates the homogeneous distribution of the brightener throughout the fabric treatment composition.Without any theoretical limitations, the applicant believes that the homogeneous distribution of the biphenyl brightener further improves the deposition of the benefit agent capsule on the fabrics. Beneficial agent capsules The fabric treatment composition comprises capsules of a beneficiation agent comprising a core material and a shell material encapsulating said core material, wherein said shell material is derived from polyvinyl alcohol and a shell component, wherein said shell component is selected from the list that 7! i Lnn / Lznz / B / Yi consists of polyacrylate, polyamine, melamine-formaldehyde, polyurea, polyurethane, polysaccharide, modified polysaccharide, formaldehyde-crosslinked urea, glutaraldehyde-crosslinked urea, silicon dioxide, sodium silicate, polyester, polyacrylamide, and mixtures thereof. The level of benefit agent capsules may depend on the desired total level of free and encapsulated benefit agent in the fabric treatment composition. In preferred fabric treatment compositions, the level of benefit agent capsules is 0.01 wt% to 10 wt%, 0.03 wt% to 5 wt%, and 0.05 wt% to 4 wt%, by weight of the fabric treatment composition. In this description, benefit agent capsule concentration means the sum of the shell material and the core material. In preferred compositions, said coating component is selected from the list consisting of polyacrylate, polyamine, polyurea, polyurethane, polysaccharide, modified polysaccharide, formaldehyde-crosslinked urea, glutaraldehyde-crosslinked urea, silicon dioxide, sodium silicate, polyester, polyacrylamide, and mixtures thereof; more preferably, said coating component is selected from the list consisting of polyamine, polyurea, polyurethane, polyacrylate, and mixtures thereof; even more preferably, said coating component is selected from polyurea, polyacrylate, and mixtures thereof; most preferably, said coating component is polyacrylate. The coating component may include approximately 50% to approximately 100%, or approximately 70% to approximately 100%, or approximately 80% to approximately 100% of a polyacrylate polymer. The polyacrylate may include a crosslinked polyacrylate polymer. The cover material may include a material selected from the group consisting of a polyacrylate, a polyethylene glycol acrylate, a polyurethane acrylate, an epoxy acrylate, a polymethacrylate, a polyethylene glycol methacrylate, a polyurethane methacrylate, an epoxy methacrylate, and mixtures thereof. The capsule shell material may include a polymer derived from a material comprising one or more polyfunctional acrylate entities. The polyfunctional acrylate entity may be selected from the group consisting of trifunctional acrylate, tetrafunctional acrylate, pentafunctional acrylate, hexafunctional acrylate, heptafunctional acrylate, and mixtures thereof. The polyfunctional acrylate entity is preferably hexafunctional acrylate. The shell material may include a polyacrylate comprising an entity selected from the group consisting of an acrylate entity, a methacrylate entity, an amine acrylate entity, an amine methacrylate entity, a carboxylic acid acrylate entity, a carboxylic acid methacrylate entity, and combinations thereof, preferably an amine methacrylate entity or 7! i Lnn / Lznz / E / Yi carboxylic acid acrylate. The cover material may include a material comprising one or more multifunctional acrylate and / or methacrylate entities. The ratio of material comprising one or more multifunctional acrylate entities to material comprising one or more methacrylate entities may be from approximately 99:1 to approximately 6:4, preferably from approximately 99:1 to approximately 8:1, with the greater preference being from approximately 99:1 to approximately 8.5:1. In one respect, the shell component is polyurea or polyurethane. Capsules can be prepared in which the shell component is derived from polyurea or polyurethane using one or more polyisocyanates and one or more crosslinking agents. A polyisocyanate is a molecule that has two or more isocyanate groups, that is, O=C=N—, where the polyisocyanate can be aromatic, aliphatic, linear, branched, or cyclic. In some forms, the polyisocyanate contains, on average, two to four —N=C=O— groups. In some forms, the polyisocyanate contains at least three isocyanate functional groups. In some forms, the polyisocyanate is insoluble in water. The polyisocyanate can be aromatic or aliphatic. Each desirable aromatic polyisocyanate has as its aromatic component a phenyl, tolyl, xylyl, naphthyl, or diphenyl entity, or a combination thereof. In certain embodiments, the aromatic polyisocyanate is a polymeric diphenylmethane diisocyanate (PMDI), a toluene diisocyanate polyisocyanurate, a toluene diisocyanate trimethylol propane adduct, or a xylylene diisocyanate trimethylol propane adduct. Suitable aliphatic polyisocyanates include hexamethylene diisocyanate trimers, isophorone diisocyanate trimers, or hexamethylene diisocyanate biurets. Additional examples include commercially available ones, e.g., BAYHYDUR N304 and BAYHYDUR N305, which are water-dispersible aliphatic polyisocyanates based on hexamethylene diisocyanate; DESMODUR N3600, DESMODUR N3700, and DESMODUR N3900, which are low-viscosity, polyfunctional aliphatic polyisocyanates based on hexamethylene diisocyanate; and DESMODUR 3600 and DESMODUR N100, which are aliphatic polyisocyanates based on hexamethylene diisocyanate, each of which is available from Bayer Corporation (Pittsburgh, PA). Specific examples of monomeric wall polyisocyanates include 1,5-naphthylene diisocyanate, 4,4'-diphenylmethane diisocyanate (MDI), hydrogenated MDI (H12MDI), xylylene diisocyanate (XDI), tetramethylxylene diisocyanate (TMXDI), 4,4'-diphenyldimethylmethane diisocyanate, di- and tetraalkyldiphenylmethane diisocyanate, 4,4'-dibenzyl diisocyanate, 1,3-phenylene diisocyanate, 1,4-phenylene diisocyanate, the isomers of tolylene diisocyanate (TDI), optionally in 7! i Lnn / Lznz / B / Yi a mixture, l-methyl-2,4-diisocyanatecyclohexane, l,6-diisocyanate-2,2,4-trimethylhexane, 1,6-diisocyanate-2,4,4-trimethylhexane, l-isocyanatemethyl-3-isocyanate-l,5,5-trimethylcyclohexane, chlorinated and brominated diisocyanates, phosphorus-containing diisocyanates, 4,4'-phenylperfluoroethane diisocyanate, tetramethoxybutane 1,4-diisocyanate, butane 1,4-diisocyanate, hexane 1,6-diisocyanate (HDI), dicyclohexylmethane diisocyanate, cyclohexane 1,4-diisocyanate, ethylene diisocyanate, bisisocyanate ethyl ester of italic acid, also polyisocyanates with atoms of reactive halogen, such as 1-chloromethylphenyl 2,4-diisocyanate, 1-bromomethylphenyl 2,6-diisocyanate, 3,3-bischloromethyl ether 4,4'-diphenyldiisocyanate. Other suitable commercially available polyisocyanates include LUPRANATE M20 (PMDI, commercially available from BASF containing 31.5 wt% NCO isocyanate groups), where the average n is 0.7; PAPI 27 (commercially available PMDI from Dow Chemical having an average molecular weight of 340 and containing 31.4 wt% NCO) where the average n is 0.7; MONDUR MR (PMDI containing 31 wt% or more NCO, commercially available from Bayer) where the average n is 0.8; MONDUR MR Light (PMDI containing 31.8 wt% NCO, commercially available from Bayer) where the average n is 0.8; MONDUR 489 (commercially available PMDI from Bayer containing 30-31.4 wt% NCO) where the average n is 1.0; poly[(phenyl isocyanate)-co-formaldehyde] (Aldrich Chemical, Milwaukee, Wis.), other isocyanate monomers such as DESMODUR N3200 (commercially available poly(hexamethylene diisocyanate) from Bayer) and TAKENATE D110-N (commercially available xylene diisocyanate adduct polymer from Mitsui Chemicals Corporation, Rye Brook, NY, containing 11.5 wt% NCO), DESMODUR L75 (a commercially available toluene diisocyanate-based polyisocyanate from Bayer), DESMODUR IL (another commercially available toluene diisocyanate-based polyisocyanate from Bayer), and DESMODUR RC (a toluene diisocyanate polyisocyanurate). The average molecular weight of certain suitable polyisocyanates ranges from 250 to 1000 Da and preferably from 275 to 500 Da. Generally, the polyisocyanate concentration ranges from 0.1% to 10%, preferably from 0.1% to 8%, with a higher preference from 0.2% to 5%, and with an even higher preference from 1.5% to 3.5%, all based on the weight of the benefit agent capsule. Each crosslinker or cross-linking agent suitable for use with polyisocyanates contains multiple (i.e., two or more) functional groups (e.g., -NH-, -NH2, and OH) that can react with polyisocyanates to form polyureas or polyurethanes. Examples include polyfunctional amines containing two or more amine groups (e.g., polyamines), polyfunctional alcohols containing two or more hydroxyl groups (e.g., polyols), epoxy crosslinkers, acrylate crosslinkers, and hybrid crosslinking agents that 7! i Lnn / Lznz / E / Yi contain one or more amine groups and one or more hydroxyl groups. Amine groups in crosslinking agents include -NH2 and R*NH, where R* is substituted and unsubstituted C1-C20 alkyl, C1-C20 heteroalkyl, C1-C20 cycloalkyl, 3- to 8-membered heterocycloalkyl, aryl, and heteroaryl. Two classes of such polyamines include polyalkyleneamines, which have the following structures: H RR N&XCnj --CH—NtCHjX, ““ CH ““ NH; Oñh HC — R in which R is hydrogen or -CH3; and each of m, n, x, yyz is independently an integer of 02000 (e.g., 1, 2, 3, 4 or 5). Examples include ethylenediamine, 1,3-diaminopropane, diethylenetriamine, triethylenetetramine, 1,4-diaminobutane, hexaethylenediamine, hexamethylenediamine, pentaethylenehexamine, melamine, and the like. Another class of polyamines are polyalkylene amines of the type: RR where R is equal to hydrogen or -CH3, m is 1-5 and n is 1-5, e.g. e.g., diethylenetriamine, triethylenetetramine and the like. Illustrative amines of this type also include diethylenetriamine, bis(3-aminopropyl)amine, bis(3-aminopropyl)-ethylenediamine, bis(hexamethylene)triamine. Another class of amine that can be used in the invention is the polyetheramine. It contains primary amino groups attached to the end of a polyether backbone. The polyether backbone is typically based on propylene oxide (PO), ethylene oxide (EO), or a mixture of PO and EO. The amine ether can be a monoamine, diamine, or triamine, based on this backbone. An example is: 7.11 Lnn / Lznz / B / Yi > ai Ν C Ν ί Illustrative polyetheramines include 2,2-(ethylenedioxy)-bis(ethylamine) and 4,7,10trioxa-1,13-tridecanediamine. Otras aminas adecuadas incluyen, pero no se limitan a, tris(2-am¡noetil)am¡na, triethylenetetramine, N,N'-bis(3-am¡noprop¡l)-l,3-propanediamine, tetraethylene pentamine, 1,2diaminopropane, 1,2-diaminoethane, Ν,Ν,Ν',Ν '-tetrakis(2-hidrox¡et¡l)et¡lend¡amine, N,N,N',N'-tetrakis(2hidrox¡prop¡l)ethylenediamine, Ν,Ν,Ν',Ν '-tetrakis(3-aminopropil)-l,4 butanodiamine, 3,5-diamino-l,2,4triazol, polietilenimina ramificada, 2,4-diam¡no-6-h¡drox¡p¡r¡m¡dina and 2,4,6-triaminopyrimidine. Branched polyethylenemines useful as breeding agents typically have a molecular weight of 200 to 2,000,000 Da (e.g., 800 to 2,000,000 Da, 2000 to 1,000,000 Da, 10,000 to 200,000 Da y 20,000 to 100,000 Da). Amphoteric amines, that is, amines that can react as both acids and bases, are another class of amines useful in this invention. Examples of amphoteric amines include proteins and amino acids such as gelatin, L-lysine, D-lysine, L-arginine, D-arginine, L-lysine hydrochloride monohydrochloride, D-lysine hydrochloride monohydrochloride, L-arginine hydrochloride monohydrochloride, D-arginine hydrochloride monohydrochloride, L-omytin hydrochloride monohydrochloride, D-omytin hydrochloride monochloride, or a mixture thereof. Guanidineamines and guanidine salts are yet another class of multifunctional amines useful in this invention. Illustrative guanidineamines and guanidine salts include, but are not limited to, 1,3-diaminoguanidine monohydrochloride, 1,1-dimethylbiguanide hydrochloride, guanidine carbonate, and guanidine hydrochloride. Commercially available examples of amines include JEFFAMINE EDR-148 which has a structure shown above (where n = 2), JEFFAMINE EDR-176 (where n = 3) (from Huntsman). Other polyetheramines include the JEFFAMINE ED series, JEFFAMINE TRIAMINES, polyethyleneimines from BASF (Ludwigshafen, Germany) under the LUPASOL grades (e.g., LUPASOL FG, LUPASOL G20 water-free, LUPASOL PR 8515, LUPASOL WF, LUPASOL FC, LUPASOL G20, LUPASOL G35, LUPASOL G100, LUPASOL G500, LUPASOL HF, LUPASOL PS, LUPASOL HEO 1, LUPASOL PNSO, LUPASOL PN6O, LUPASOL P0100 and LUPASOL SK). Other commercially available polyethyleneimines include EPOMIN P-1000, EPOMIN P-1050, EPOMIN RP18W, and EPOMIN PP 061 from NIPPON SHOKUBAI (New York, NY). Polyvinylamines such as those marketed by BASF under the LUPAMINE grade can also be used. Skilled practitioners can select from a wide range of polyetheramines.In certain forms, the crosslinking agent is hexamethylenediamine, polyetheramine, or a mixture of these. The range of polyfunctional amines, polyfunctional alcohols, or hybrid crosslinking agents can vary from 0.1% to 5% (e.g., 0.2% to 3%, 0.2% to 2%, 0.5% to 2%, or 0.5% to 1%) by weight of the beneficiation agent capsule The capsules may comprise an emulsifier, wherein the emulsifier is preferably selected from anionic emulsifiers, non-ionic emulsifiers, cationic emulsifiers or mixtures thereof, preferably non-ionic emulsifiers. The capsule shell material is derived from polyvinyl alcohol, preferably at a level of 0.01 to 20%, more preferably 0.05% to 10%, even more preferably 0.1% to 5%, with the highest preference being 0.1% to 2% by weight of the capsules. The polyvinyl alcohol may reside partially within the capsule shell and may reside partially on the outer surface of the shell. Preferably, polyvinyl alcohol has at least one of the following properties, or a mixture of these: (i) a degree of hydrolysis of 70% to 99%, preferably 75% to 98%, with greater preference of 80% to 96%, with greater preference of 82% to 96%, with the highest preference of 86% to 94%; (i) a viscosity of 2 mPa.s 150 mPa.s, preferably 3 mPa.s 70 mPa.s, more preferably 4 mPa.s 60 mPa.s, even more preferably 5 mPa.s 55 mPa.s in 4% aqueous solution at 20 °C. In preferred compositions for the treatment of fabrics, the weight ratio of polyvinyl alcohol to biphenyl brightener is 1 / 1 to 1 / 5000, preferably 1 / 2 to 1 / 2000, with a higher preference of 1 / 5 to 1 / 1000, with the highest preference of 1 / 10 to 1 / 500. Suitable polyvinyl alcohol materials can be selected from Selvol 540 PVA (Sekisui Specialty Chemicals, Dallas, TX), Mowiol 18-88 = Poval 18-88, Mowiol 3-83, Mowiol 498 = Poval 4-98 (Kuraray), Poval KL-506 = Poval 6-77 KL (Kuraray), Poval R-1130 = Poval 25-98 R (Kuraray), Gohsenx K-434 (Nippon Gohsei). Perfume compositions are the preferred encapsulated beneficial agent that enhances the scent of fabrics treated with fabric treatment compositions. The perfume composition comprises perfume raw materials. The encapsulated beneficial agent may also include essential oils, odor-reducing agents, odor-control agents, silicone, and combinations thereof. Perfume raw materials are typically present in an amount of 10% to 99%, preferably 20% to 98%, with greater preference 70% to 96%, by weight of the capsule. The perfume composition may comprise from 2.5% to 30%, preferably 7! i Lnn / Lznz / E / Yi of 5% to 30% by weight of the perfume composition of perfume raw materials characterized by a logP less than 3.0 and a boiling point less than 250 °C. The perfume composition may comprise from 5% to 30%, preferably from 7% to 25% by weight, of perfume raw materials characterized by having a logP less than 3.0 and a boiling point greater than 250 °C. The perfume composition may comprise from 35% to 60%, preferably from 40% to 55% by weight, of perfume raw materials characterized by having a logP greater than 3.0 and a boiling point less than 250 °C. The perfume composition may comprise from 10% to 45%, preferably from 12% to 40% by weight, of perfume raw materials characterized by having a logP greater than 3.0 and a boiling point greater than 250 °C. Preferably, the core further comprises a partitioning modifier. Suitable partitioning modifiers include vegetable oil, modified vegetable oil, propan-2-yltetradecanoate, and mixtures thereof. The modified vegetable oil may be esterified and / or brominated. The vegetable oil comprises castor oil and / or soybean oil. The partitioning modifier may be propan-2-yltetradecanoate. The partitioning modifier may be present in the core at a level, based on the total weight of the core, greater than 10%, or from greater than 10% to approximately 80%, or from greater than 20% to approximately 70%, or from greater than 20% to approximately 60%, or from approximately 30% to approximately 60%, or from approximately 30% to approximately 50%. Preferably, the capsules have a volume-weighted average particle size of 0.5 micrometers to 100 micrometers, preferably 1 micrometer to 60 micrometers, even more preferably 5 micrometers to 45 micrometers. For example, polyacrylate beneficiation agent capsules can be purchased from Encapsys (East Wisconsin Ave, 825, Appleton, WI 54911) and can be prepared as follows with, for example, perfume as the beneficiation agent: A first oil phase, consisting of 37.5 g of perfume, 0.2 g of tert-butylaminoethyl methacrylate, and 0.2 g of beta-hydroxyethyl acrylate, is mixed for approximately 1 hour before the addition of 18 g of CN975 (Sartomer, Exter, PA). The solution is mixed until subsequently required for the process. A second oil phase, consisting of 65 g of perfume oil, 84 g of isopropyl myristate, 1 g of 2,2'-azobis(2-methylbutyronitrile), and 0.8 g of 4,4'-azobis[4-cyanovaleric acid], is added to a lined steel reactor. The reactor is maintained at 35 °C, and the oil solution is mixed at 500 rpm using a 2-inch flat paddle mixer. A nitrogen blanket is applied to the reactor at a rate of 300 cc / min. The solution is heated to 70 °C in 45 minutes. 7! i Lnn / Lznz / E / Yi and is held at 70 °C for 45 minutes, before cooling to 50 °C in 75 minutes. The first oil phase is added at 50 °C, and the combined oils are mixed for another 10 minutes at 50 °C. An aqueous phase is prepared, containing 85 g of Selvol 540 PVA (Sekisui Specialty Chemicals, Dallas, TX) at 5% solids, 268 g of water, 1.2 g of 4,4'-azobis[4-cyanovaleric acid], 1.1 g of 21.5% NaOH, and mixed until the 4,4'-azobis[4-cyanovaleric acid] is dissolved. Once the temperature of the oil phase has been reduced to 50 °C, mixing is stopped and the aqueous phase is added to the blended oils. High shear agitation is applied to produce an emulsion with the desired size characteristics (1900 rpm for 60 minutes). Then, the temperature is increased to 75°C in 30 minutes, maintained at 75°C for 4 hours, heated to 95°C in 30 minutes and maintained at 95°C for 6 hours. Surfactant In preferred compositions for the treatment of fabrics, the composition further comprises a surfactant at a level of 1% by weight to 70% by weight, preferably from 10% by weight to 40% by weight, with greater preference from 15% by weight to 30% by weight. The surfactant generally comprises an anionic surfactant. In preferred compositions for the treatment of fabrics, the surfactant may comprise the anionic surfactant at a level of 1% to 50% by weight, preferably from 10% to 40% by weight, and more preferably from 15% to 30% by weight. Suitable anionic surfactants can be selected from the group consisting of alkyl sulfates, ethoxyalkyl sulfates, alkyl sultanates, alkylbenzene sultanates, fatty acids and their salts, and mixtures thereof. However, by nature, all known anionic surfactants can be used in the technique of detergent compositions, as described in Surfactant Science Series, Vol. 7, edited by W.M. Linfield and Marcel Dekker. Nevertheless, the base mixture preferably comprises at least one sulfonic acid surfactant, such as a linear alkylbenzene sulfonic acid, but water-soluble salt forms can also be used. The anionic sultanate or sulfonic acid surfactants suitable for use in the present description include the acid and salt forms of linear or branched C5-C20 alkylbenzene sultanates, more preferably C10-C16, more preferably C11-C13, C5-C20 alkyl ester sultanates, C6-C22 primary or secondary alkane sultanates, C5-C20 sulfonated polycarboxylic acids, and any mixture thereof, but preferably C11-C13 alkylbenzene sultanates. The surfactants mentioned above may vary widely in their 2-phenyl isomer content. The anionic sulfate salts suitable for use in the compositions of 7! i Lnn / Lznz / E / Yi invention include primary and secondary alkyl sulfates, having a linear or branched alkyl or alkenyl entity having 9 to 22 carbon atoms or more preferably 12 to 18 carbon atoms. Also useful are commercially available beta-branched alkyl sulfate surfactants or mixtures of materials having a weight-average degree of branching (of the surfactant or mixture) of at least 50%. Medium-chain branched alkyl sulfates or sulfonates are also suitable anionic surfactants for use in the compositions of the invention. Medium-chain branched primary alkyl sulfates C5-C22, preferably C10-C20, are preferred. When mixtures are used, a suitable average total number of carbon atoms for the alkyl entities is preferably in the range of greater than 14.5 to 17.5. The preferred monomethyl-branched primary alkyl sulfates are selected from the group consisting of 3-methyl to 13-methyl pentadecanol sulfates, the corresponding hexadecanol sulfates, and mixtures thereof. Similarly, dimethyl derivatives or other biodegradable alkyl sulfates with little branching may be used. Other anionic surfactants suitable for use in the present description include fatty methyl ester alkoxy sulfonates and / or alkyl sulfates such as alkyl ethoxy sulfates (AES) and / or alkyl polyalkoxylated carboxylates (AEC). Anionic surfactants are typically present in the form of their salts with alkanolamines or alkali metals such as sodium and potassium. For improved stability, the fabric treatment composition may comprise a linear alkylbenzene sulfonate surfactant and an alkoxylated alkyl sulfate surfactant, such that the ratio of the linear alkylbenzene sulfonate surfactant is 0.1 to 5, preferably 0.25 to 3, more preferably 0.75 to 1.5. When used, the alkoxylated alkyl sulfate surfactant is preferably a mixture of one or more ethoxylated alkyl sulfates, more preferably having a degree of ethoxylation of 1 to 10, most preferably 1.8 to 4. The fabric treatment composition may include a non-ionic surfactant. The level of non-ionic surfactant in the fabric treatment composition may be less than 10% by weight, preferably less than 5% by weight, more preferably less than 1% by weight, and most preferably less than 0.5% by weight. Suitable nonionic surfactants include, but are not limited to, C12-C18 alkyl ethoxylates (AE) including so-called narrow-peaked C6-C12 alkylphenol ethoxylates and alkoxylates (especially mixed ethoxylates and ethoxy / propoxy), C6-C12 alkylphenol block alkylene oxide condensates, C8-C22 alkandes alkylene oxide condensates, and ethylene oxide / propylene oxide block polymers (Pluronic - BASF Corp.), as well as semipolar nonionic compounds (e.g., amine oxides and phosphine oxides). 7! i Lnn / Lznz / E / Yi to be used in the present compositions. U.S. Patent No. 3,929,678, Laughlin et al., published December 30, 1975, contains an extensive description of these types of surfactants. Alkylpolysaccharides such as those described in U.S. Patent No. 4,565,647, Filling, are also useful nonionic surfactants in the compositions of the invention. Alkyl polyglucoside surfactants are also suitable. In some embodiments, useful nonionic surfactants include those of the formula Ri(OC2H4)nOH, where Ri is a C10-C16 alkyl group or a C8-C12 alkylphenyl group, and n is preferably from 3 to 80. In some embodiments, nonionic surfactants can be condensation products of C12-C15 alcohols with 5 to 20 moles of ethylene oxide per mole of alcohol, e.g., C12-C13 alcohol condensed with 6.5 moles of ethylene oxide per mole of alcohol. Other suitable non-ionic surfactants include fatty acid polyhydroxyamides of the formula: 7! i Lnn / Lznz / E / Yi R—C—N—Z, where R is a C9-17 alkyl or alkenyl group, R1 is a methyl group, and Z is a glycidyl group derived from a reduced sugar or an alkoxylated derivative thereof. Examples include N-methyl-N1-deoxyglucityl cocoamide and N-methyl-N1-deoxyglucityl oleamide. Processes for preparing polyhydroxyamides of fatty acids are known and can be found in Wilson, U.S. Patent No. 2,965,576 and Schwartz, U.S. Patent No. 2,703,798. The fabric treatment composition may include a zwitterion. Even low levels of the zwitterion have been found to improve the stability of fabric treatment compositions, particularly compositions containing little or no non-aminofunctional organic solvent. The zwitterion may be present at a level of 0.1 wt% to 5 wt%, preferably 0.2 wt% to 2 wt%, with 0.4 wt% to 1 wt% being more preferable. Zwitterionic detergent surfactants include those known for use in hair care or other personal care cleansing. Non-limiting examples of suitable zwitterions are described in U.S. Patents 5,104,646 (Bolich Jr. et al.) and 5,106,609 (Bolich Jr. et al.). Zwitterionic detergent surfactants are known in the art and include surfactants generally described as derivatives of aliphatic, phosphonium, and sulfonium quaternary ammonium compounds, wherein the aliphatic radicals may be straight-chain or branched, and where one of the aliphatic substituents contains 8 to 18 carbon atoms and another contains an anionic group such as carboxy, sulfonate, sulfate, phosphate, or phosphonate. Betaines are also suitable zwitterionic surfactants. The fabric treatment composition may comprise a zwitterionic polyamine. Suitable zwitterionic polymers may comprise a polyamine backbone in which the backbone units connecting the amino units may be modified by the formulator to achieve different levels of product enhancement, including, among others, enhanced clay soiling removal by surfactants and greater efficiency in the use of heavily soiled loads. In addition to modifying the backbone composition, the formulator may preferably substitute one or more of the hydrogens of the amino unit of the backbone with other units, including, among others, alkylenoxy units having a terminal anionic entity. Furthermore, the nitrogens of the backbone may be oxidized to the N-oxide. Preferably, at least two of the nitrogens of the polyamine backbone are quaternized. Solvent The fabric treatment composition may include a non-amino functional organic solvent. If present, the non-amino functional organic solvent is preferably present at a level of less than 40%, most preferably less than 15% by weight, most preferably from 1% to 10%, most preferably from 1.2% to 7.5%, and most preferably from 1.2% to 5.0% by weight of the non-amino functional organic solvent. As used herein, non-amino functional organic solvent refers to any solvent that does not contain amino functional groups, in fact, that does not contain nitrogen. Non-amino functional organic solvents include, for example: C1-C5 alkanols such as methanol, ethanol, and / or propanol and / or 1-ethoxypentanol; C2-C6 diols; C3-C8 alkylene glycols; C3-C8 lower monoalkyl alkyl ethers; glycol dialkyl ethers; and low molecular weight polyethylene glycols. C3-C9 triols such as glycerol; and mixtures thereof.More specifically, non-aminofunctional solvents are liquids at room temperature and pressure (i.e., 21 °C and 1 atmosphere), and comprise carbon, hydrogen, and oxygen. If used, mixtures of non-aminofunctional organic solvents are highly preferred, especially mixtures of lower aliphatic alcohols such as propanol, butanol, isopropanol, and / or diols such as 1,2-propanediol or 1,3-propanediol; glycerol; diethylene glycol; or mixtures thereof. Propanediol (especially 1,2-propanediol), or mixtures of propanediol with diethylene glycol, are preferred. 7! i Lnn / Lznz / E / Yi Hydrotrope The composition suitable for treating fabrics may include a hydrotrope. If present, hydrotropes are preferably present at a level of less than 1%, most preferably at a level of 0.1% to 0.5% by weight of the liquid composition. Suitable hydrotropes include anionic hydrotropes, particularly sodium, potassium, and ammonium xylenesulfonate, sodium, potassium, and ammonium toluenesulfonate, sodium, potassium, and ammonium cumenesulfonate, and mixtures thereof, as described in U.S. Patent No. 3,915,903. For the avoidance of doubt, hydrotropes, which are also zwitterions, are considered zwitterions for the compositions of the present invention. Salt The fabric treatment composition may include a non-surfactant salt selected from the group consisting of: sodium carbonate, sodium bicarbonate, magnesium chloride, ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), hydroxyethanediphosphonic acid (HEDP), sodium citrate, sodium chloride, citric acid, calcium chloride, sodium formate, diethylenetriaminepentamethylphosphonic acid, and mixtures thereof. Such non-surfactant salts may be used to increase the amount of liquid crystalline phase present, especially the lamellar phase. The non-surfactant salt may be added to provide a level of 1.5 wt to 10 wt, more preferably 2.5 wt to 7 wt, with the highest preference 3 wt to 5 wt of the non-surfactant salt in the fabric treatment composition. The composition for the treatment of fabrics preferably comprises from 15% to 85%, preferably from 5% to 70%, with greater preference from 10% to 60% of the liquid crystalline phase. Preferably, the fabric treatment composition comprises water. The water content may be present at a level of 10% to 90%, preferably 25% to 80%, with the highest preference being 45% to 70% by weight of the fabric treatment composition. Auxiliary materials The fabric treatment composition may include additional ingredients, such as those selected from the group consisting of: polymeric deposition auxiliary, organic additive and / or chelating agent, enzymes, enzyme stabilizers, toning dyes, particulate matter, cleaning polymers, external structuring agents, and mixtures thereof. Polymer deposition auxiliary: The base mixture may comprise from 0.1% to 7%, more preferably from 0.2% to 3%, of a polymer deposition auxiliary. As used in the 7! i Lnn / Lznz / B / Yi In this description, a polymeric deposition aid refers to any cationic polymer or combination of cationic polymers that, during washing, significantly enhances the deposition of a fabric care benefit agent onto the fabric. Suitable polymeric deposition aids may comprise a cationic polysaccharide and / or a copolymer. As used herein, a benefit agent refers to any material that can provide fabric care benefits. Non-limiting examples of fabric care benefit agents include silicone derivatives, oily sugar derivatives, dispersible polyolefins, polymeric latexes, cationic surfactants, and combinations thereof. Preferably, the deposition aid is a cationic or amphoteric polymer. The cationic charge density of the polymer preferably ranges from 0.05 milliequivalents / g to 6 milliequivalents / g.Charge density is calculated by dividing the number of net charges per repeating unit by the molecular weight of the repeating unit. In one embodiment, the charge density varies from 0.1 milliequivalents / g to 3 milliequivalents / g. Positive charges may be located on the polymer backbone or on the polymer side chains. Organic additive and / or chelating agent: The base mixture may comprise from 0.6% to 10%, preferably from 2% to 7% by weight of one or more organic additives and / or chelating agents.Organic additives and / or chelating agents are selected from the group consisting of: MEA-citrate, citric acid, aminoalkylene poly(alkylene phosphonates), ethane 1-hydroxy diphosphonates of alkali metals, and nitrilotrimethylene, phosphonates, diethylenetriaminopenta(methylenephosphonic acid) (DTPMP), tetraethylenediaminepenta(methylenephosphonic acid) (DDTMP), hexamethylenediaminetetra(methylenephosphonic acid), hydroxyethylene 1,1-diphosphonic acid (HEDP), hydroxyethane dimethylenephosphonic acid, ethylenediaminedisuccinic acid (EDDS), ethylenediaminetetraacetic acid (EDTA), hydroxyethylethylenediamine triacetate (HEDTA), nitrilotriacetate (NTA), methylglycine diacetate (MGDA), iminodisuccinate (IDS), hydroxyethyliminodisuccinate (HIDS), hydroxyethyliminodiacetate (HEIDA), glycine diacetate (GLDA), diethylenetriaminepentaacetic acid (DTPA), catechol sulfonates such as TironTM and mixtures of these. Toning Dyes: Toning dyes, also known as colorants or fabric toning agents, are useful washing aids in fluid laundry detergent compositions. The history of these materials in laundry is long, originating with the use of laundry bluing agents many years ago. More recent developments include the use of sulfonated phthalocyanine dyes with a central zinc or aluminum atom; and even more recently, a wide variety of other blue and / or violet dyes have been used for their toning effects. See, for example, patents WO 2009 / 087524 A1, WO 2009 / 087034 A1, and references cited therein. The fluid laundry detergent compositions described herein typically comprise from 0.00003% by weight to 0.1% by weight of 7! i Lnn / Lznz / B / Yi 0.00008% by weight to 0.05% by weight, or even from 0.0001% by weight to 0.04% by weight, of fabric toning agent. Particulate material: Suitable particulate materials include clays, foam suppressants, and microcapsules, for example, containing encapsulated ingredients such as perfumes, bleaches, and enzymes; or additional aesthetic ingredients such as pearlescent agents, pigment particles, mica, or similar materials. Preferred particulate materials are particularly microcapsules, especially perfume microcapsules. Microcapsules are typically formed by surrounding, at least partially, and preferably completely, a beneficial agent with a wall material. Preferably, the microcapsule is a perfume microcapsule, where the beneficial agent comprises one or more perfume raw materials. Suitable usage levels are 0.0001% to 5% or 0.1% to 1% by weight of the fabric treatment composition. Perfume: Suitable perfumes are known in the art, and are typically incorporated at a level of 0.001 to 10%, preferably 0.01% to 5%, with greater preference for 0.1% to 3% by weight. Cleaning Polymers: Suitable cleaning polymers provide broad-spectrum cleaning of soils from surfaces and fabrics and / or soil suspensions. Any suitable cleaning polymer may be useful. Useful cleaning polymers are described in patent no. USPN 2009 / 0124528A1. Non-limiting examples of useful categories of cleaning polymers include: amphiphilic alkoxylated grease-cleaning polymers; clay-based stain-cleaning polymers; stain-removing polymers; and soil-suspension polymers. External structuring agents: The preferred external structuring agents are uncharged external structuring agents, such as those selected from the group consisting of: crystalline non-polymeric structuring agents with hydroxyl functionality, such as hydrogenated castor oil; microfibrillated cellulose; uncharged hydroxyethylcellulose; uncharged hydrophobically modified hydroxyethylcellulose; hydrophobically modified ethoxylated urethanes; hydrophobically modified non-ionic polyols; and mixtures thereof. Use of a fabric treatment composition comprising a biphenyl brightener The applicants have surprisingly discovered that biphenyl brighteners in a fabric treatment composition according to the present invention provide improved deposition of the beneficial agent capsules. Without any theoretical limitations, the applicants believe that the improved deposition, particularly the affinity for cotton fabrics, is due to the interaction between the biphenyl brightener and the polyvinyl alcohol in the beneficial agent capsules. 7! i Lnn / Lznz / E / Yi Methods Method for treating fabrics Miele W1714 Softtronic washing machines were used to treat the fabrics. For each treatment, the washing machine was loaded with 3 kg of fabric, comprising 1500 g of woven cotton fabric and 1100 g of polyester-cotton (50 / 50) fabrics. Six terry cloth tracers (supplied by Maes Textiles), weighing a total of 260 g, were also added for void space analysis. This load was pre-conditioned twice with 79 g of unscented IEC A Base detergent, supplied by WFK Testgewebe GmbH, using the short 95 °C cotton cycle, followed by two additional 95 °C washes without detergent. For the test treatment, the load was washed using a short 30 °C synthetic cycle with 60 g of the fabric treatment composition, which was added at the beginning of the wash cycle using a dosing ball.After washing, the terry cloth tracers are dried on the line and analyzed using the following method to determine the concentration of the void space above the treated fabrics. Method for determining the concentration of empty space above treated fabrics At the end of the wash cycle, the terry cloth tracers are removed from the washing machine and dried on the line overnight. The following day, the dried terry cloth tracers are analyzed for void space using a fast GC / MS (gas chromatography-mass spectrometry) method. 4 x 4 cm aliquots of the terry cloth tracers are transferred to 25 ml void space flasks. The cloth samples are equilibrated for 10 minutes at 75 °C. Void space samples are taken from the cloths using SPME focusing (50 / 30 pm DVB / Carboxene / PDMS) for 5 minutes. The SPME fiber is subsequently thermally desorbed online in the GC. The analytes are analyzed by fast GC / MS in full scan mode. Ion extraction of the specific masses of the perfume raw materials is used to calculate the total HS response and the perfume void space composition above the tested rounds.The results are reported as a void space index where the dry void space of the test treatment is expressed as a ratio versus the reference treatment which has an index of 1. Method for measuring the viscosity of polyvinyl alcohol solution Viscosity is measured using a Brookfield LV series viscometer or equivalent, measured at 4.00% + / - 0.05% solids. a. A solid solution of polyvinyl alcohol at 4.00% + / - 0.05% is prepared. A 500 mL beaker and stirrer are weighed and their weights recorded. 16.00 ± 0.01 grams of a polyvinyl alcohol sample are added to the beaker. Approximately 350–375 mL of [unspecified liquid] is then added. 7! Add deionized water to the beaker and stir the solution. Place the beaker in a hot water bath with the cover plate. Stir at a moderate speed for 45 minutes to 1 hour, or until the polyvinyl alcohol is completely dissolved. Turn off the stirrer. Cool the beaker to approximately 20 °C. 7! i Lnn / Lznz / E / Yi The final weight of the glass is calculated as follows: Final weight = (weight of stirrer and empty beaker) + (% solids as a decimal x 400) Example: Weight of stirrer and empty beaker = 125.0 grams % of polyvinyl alcohol solids (of the sample) = 97.50% or 0.9750 as a decimal Final weight=125.0 + (0.9750 x 400)=515.0 grams A top-loading balance is zeroed, and the beaker containing the polyvinyl alcohol solution with a propeller is placed on it. Deionized water is added to adjust the weight to the final calculated weight of 515.0 grams. The solids content of the sample must be 4.00 + 0.05% to measure viscosity. b. Viscosity measurement The 4% polyvinyl alcohol solution sample is dispensed into the viscometer chamber, the spindle is inserted, and it is connected to the viscometer. The sample adapter (SSA) with chamber is SC4-13RPY, and the Ultralow adapter is used. The spindles are SC4-18 and 00. The sample is allowed to reach equilibrium at 20 °C. The viscometer is started, and the steady-state viscosity value is recorded. Viscosity <13 cP is reported to the nearest 0.01 cP, 13-100 cP to the nearest 0.1 cP; viscosities greater than 100 cP are reported to the nearest 1 cP. Corrections to the determined viscosity are not necessary if the calculated solution solids content is 4.00 ± 0.05%. Otherwise, use the following equation to correct the determined viscosity for deviations in solution solids. Corrected LogeViscosity = (Measured Logviscosity) (percent solids) x (0.2060) + (0.1759) Corrected viscosity = 2.718282 (log of corrected viscosity) Examples The polyacrylate beneficiation agent capsules comprising perfume are prepared as follows: a first oily phase, consisting of 37.5 g of perfume, 0.2 g of tert-butylaminoethyl methacrylate and 0.2 g of beta hydroxyethyl acrylate, is mixed for approximately 1 hour before the addition of 18 g of CN975 (Sartomer, Exter, PA). The solution is left to mix until required later in the process. A second oil phase, consisting of 65 g of perfume oil, 84 g of isopropyl myristate, 1 g of 2,2'-azobis(2-methylbutyronitrile), and 0.8 g of 4,4'-azobis[4-cyanovaleric acid], is added to a lined steel reactor. The reactor is maintained at 35 °C, and the oil solution is mixed at 500 rpm using a 2-inch flat paddle mixer. A nitrogen blanket is applied to the reactor at a rate of 300 cc / min. The solution is heated to 70 °C in 45 minutes and held at 70 °C for 45 minutes before being cooled to 50 °C in 75 minutes. The first oil phase is added at 50 °C, and the combined oils are mixed for a further 10 minutes at 50 °C. An aqueous phase is prepared, containing 85 g of Selvol 540 PVA (Sekisui Specialty Chemicals, Dallas, TX) at 5% solids, 268 g of water, 1.2 g of 4,4'-azobis[4-cyanovaleric acid], 1.1 g of 21.5% NaOH, and mixed until the 4,4'-azobis[4-cyanovaleric acid] is dissolved. Once the temperature of the oil phase is reduced to 50 °C, mixing is stopped and the aqueous phase is added to the blended oils. High shear agitation is applied to produce an emulsion with the desired size characteristics (1900 rpm for 60 minutes). Then, the temperature is increased to 75°C in 30 minutes, maintained at 75°C for 4 hours, heated to 95°C in 30 minutes and maintained at 95°C for 6 hours. Examples 1 to 4 of fabric treatment compositions were prepared as described below. Water, sodium hydroxide, and solvents were mixed in a plastic cup using a paddle mixer. Surfactants, chelating agents, additives, and polymers were added to this mixture during mixing. The final pH was reduced with ethanolamine to a pH (10% dilution) of approximately 8. The mixture is then cooled to room temperature, and during further mixing, dye, enzymes, polymers, preservatives, processing aids, and a structuring agent are added. In Examples 2 and 4, the biphenyl brightener premix was also added, starting with a brightener premix. Brightener premix 49 is supplied by 7! i Lnn / Lznz / E / Yi Calvary Industries, and the brightener 49 is 8.4% active in an aqueous solution of 1,2-propanediol and ethoxylated alcohol. Polish 49 corresponds to the formula 7! i Lnn / Lznz / E / Yi where M corresponds to Na+. The premixes were prepared to allow for homogeneous distribution of the brightener in all compositions. The detailed composition of the fabric treatment compositions (Ex. 1-4) is provided in Table 1. Table 1: Compositional details of examples 1-4. Example 1 is a comparative example indicated with an asterisk. Ex. 1* Ex. 2 Ex. 3 Ex. 4 Level [% active] Alkyl ether sulfate 3.96 3.96 3.96 3.96 Dodecylbenzene sulfonic acid 9.15 9.15 9.15 9.15 Ethoxylated alcohol 3.83 3.83 3.83 3.83 Amine oxide 0.51 0.51 0.51 0.51 Fatty acid 1.73 1.73 1.73 1.73 Citric acid 2.79 2.79 2.79 2.79 Diethylenetriaminepentamethylenephosphonic acid sodium salt 0.512 0.512 0.512 0.512 Calcium chloride 0.011 0.011 0.011 0.011 sodium formate 0.034 0.034 0.034 0.034 Quaternized hexamethylenediamine ethoxysulfate 0.664 0.664 0.664 0.664 Polyethylene glycol and vinyl acetate copolymer 1.27 1.27 1.27 1.27 Polyacrylate beneficiation agent capsules comprising perfume wherein the cover material is derived from polyvinyl alcohol 0.33 0.33 0.33 0.33 1,2-Benzisothiazolin-3-one and 2-Methyl-4-isothiazolin-3-one 0.005 0.005 0.005 0.005 Ethanol 0.42 0.42 0.42 0.42 1,2-Propanediol 1.259 1.259 1.259 1.259 Sodium cumene sulfonate 1.724 1.724 1.724 1.724 Monoethanolamine 0.24 0.24 0.24 0.24 NaOH 3.1 3.1 3.1 3.1 Hydrogenated castor oil structural agent 0.3 0.3 0.3 0.3 Silicone emulsion 0.0025 0.0025 0.0025 0.0025 Dye 0.0054 0.0054 0.0054 0.0054 Water and brightener premix auxiliaries (when optical brightener is present) Balance Balance Balance Balance Balance 0 Optical brightener level 49 0.0 0.1 0.2 0.3 Dry void space index 1.00 ± 0.03 1.34 ± 0.05 1.58 ± 0.16 1.46 ± 0.14 7! i Lnn / Lznz / B / Yi Table 1 clearly shows that the void space above the fabrics treated with compositions according to the present invention (Ex. 2-4) was greater than that of Comparative Example 1, which does not include the biphenyl brightener. Since the measurement of the void space 5 records the concentration of perfume raw materials that were originally encapsulated in the benefiting agent capsules, an increase in the concentration of the void space can be related to greater deposition from the benefiting agent capsules. Furthermore, it can be observed that higher levels of biphenyl brightener (Ex. 3-4) showed a further improvement in the void space and, therefore, in the deposition compared to lower levels of biphenyl brightener 10 (Ex. 2). The dimensions and values ​​described herein should not be understood as strictly limited to the exact numerical values ​​stated. Instead, unless otherwise specified, each such dimension shall mean the stated value and a functionally equivalent range encompassing that value. For example, a dimension described as 40 mm refers to approximately 40 mm. NOVELTY OF THE INVENTION 7! i Lnn / Lznz / E / Yi

Claims

1. A fabric treatment composition comprising: a) Beneficiation agent capsules characterized in that the benefit agent capsules comprise a shell material encapsulating a core material wherein the shell material is derived from polyvinyl alcohol and a shell component wherein the shell component is selected from the list consisting of polyacrylate, polyamine, melamine formaldehyde, polyurea, polyurethane, polysaccharide, modified polysaccharide, formaldehyde-crosslinked urea, glutaraldehyde-crosslinked urea, silicon dioxide, sodium silicate, polyester, polyacrylamide, and mixtures thereof; the core material comprising a benefit agent; b) a biphenyl brightener having the formula: wherein M is a suitable cation.

2. The fabric treatment composition according to claim 1, characterized in that the coating component is selected from the list consisting of polyacrylate, polyamine, polyurea, polyurethane, polysaccharide, modified polysaccharide, formaldehyde-crosslinked urea, glutaraldehyde-crosslinked urea, silicon dioxide, sodium silicate, polyester, polyacrylamide, and mixtures thereof; preferably the coating component is selected from the list consisting of polyamine, polyurea, polyurethane, polyacrylate, and mixtures thereof; more preferably the coating component is selected from polyurea, polyacrylate, and mixtures thereof.

3. The fabric treatment composition according to any preceding claim characterized in that the biphenyl brightener level is from 0.01% to 2%, preferably from 0.04% to 1.5%, more preferably from 0.06% to 1%, most preferably from 0.1% to 0.5% by weight of the fabric treatment composition.

4. The fabric treatment composition according to any of the preceding claims, characterized in that the level of polyvinyl alcohol is from 0.01 to 20%, preferably from 0.05 to 10%, even more preferably from 0.1 to 5%, with the highest preference being from 0.1 to 2% by weight of the benefit agent capsules.

5. The fabric treatment composition according to any of the preceding claims, characterized in that the polyvinyl alcohol has a degree of hydrolysis of 70% to 99%, preferably 75% to 98%, more preferably 80% to 96%, most preferably 82% to 96%.

6. The fabric treatment composition according to any of the preceding claims, characterized in that the polyvinyl alcohol as a 4% wt% solution in water has a viscosity of 2 mPa.s to 150 mPa.s, preferably 3 mPa.s to 70 mPa.s, more preferably 4 mPa.s to 60 mPa.s, most preferably 5 mPa.s to 55 mPa.s.

7. The fabric treatment composition according to any of the preceding claims, characterized in that the weight ratio of polyvinyl alcohol to biphenyl brightener is from 1 / 1 to 1 / 5000, preferably from 1 / 2 to 1 / 2000, more preferably from 1 / 5 to 1 / 1000, with the highest preference from 1 / 10 to 1 / 500.

8. The fabric treatment composition according to any preceding claim characterized in that the ratio of biphenyl brightener to benefit agent capsules is 50 / 1 to 1 / 500, more preferably 10 / 1 to 1 / 250, most preferably 5 / 1 to 1 / 100.

9. The fabric treatment composition according to any preceding claim characterized in that the core material comprises perfume.

10. The fabric treatment composition according to any preceding claim, characterized in that the fabric treatment composition further comprises a surfactant selected from non-ionic, anionic, cationic, zwitterionic surfactants and combinations thereof.

11. The fabric treatment composition according to any preceding claim characterized in that the surfactant level is from 1% by weight to 70% by weight, preferably from 10% by weight to 40% by weight, more preferably from 15% by weight to 30% by weight of the fabric treatment composition.

12. The fabric treatment composition according to any preceding claim characterized in that the level of benefit agent capsules is from 0.01% by weight to 10% by weight, 0.03% by weight to 5% by weight, 0.05% by weight to 4% by weight, in the fabric treatment composition.

13. The fabric treatment composition characterized in that the biphenyl brightener is premixed before addition to the remaining ingredients and wherein the premix comprises the biphenyl brightener, water and a component selected from the list consisting of organic solvents, non-ionic surfactant, and mixtures thereof; preferably wherein the organic solvent is 1,2-propanediol.

14. Wash water comprising the fabric treatment composition according to any of the preceding claims, characterized in that the level of 5-biphenyl brightener is from 0.1 to 50 ppm, preferably from 1 to 30 ppm, more preferably from 2 to 20 ppm by weight of the wash water.

15. Use of a biphenyl brightener in a composition according to any preceding claim to increase the deposition of benefit agent capsules on fabrics, preferably characterized in that the fabrics are cotton fabrics.